INTRODUCTION:
Social determinants of health (SDOHs) affect disease risk and severity leading to health disparities. SDOH impacting metabolic dysfunction-associated steatotic liver disease ...
A continuous course of hepatic fat loss with fibrosis progression, referred to as “burning-out,” was observed in patients with metabolic dysfunction–associated steatotic liver disease. These ...
Hepatic stellate cells (HSCs) play a crucial role in the pathogenesis of liver fibrosis in metabolic dysfunction–associated steatohepatitis (MASH), a condition characterized by excessive fat ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) are associated with adverse clinical outcomes, impaired health-related quality of life, and large ...